Envision Report

Published January 11, 2018

Europe Protein Expression Market – Size, Outlook, Trends, and Forecasts (2018 – 2024)

Request Free Sample Report!

Protein Expression is an ability to control, produce and change the protein in an organism. In research, the term protein expression refers to the laboratory technique or material of study to formulate proteins. Recombining of protein expression is of three types, in-vivo protein expression, in-vitro protein expression and chemical protein synthesis. A large number of opportunities is in proteomics and biotechnology which mostly depend on protein expression to reduce the side effects and for various therapies.

Europe Protein Expression Market Segments Size & Growth:

Europe Protein Expression Market is accounted for $ 4.2 billion in 2017 and expected to grow at a CAGR of 8.4% to reach $6.72 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth an increase in chronic diseases like diabetes and cancer, development in biologics such as therapeutic proteins, vaccines, high investments for drug designing, advancement in biotechnology, biopharmaceutical and so on. However, government regulations for manufacturing biologics hinder the growth of the protein expression market.

Europe Protein Expression Market Segments Share:

Europe Protein Expression Market is categorised into by expression type which consists of prokaryotic, yeast, cell-free, mammalian and so on. The prokaryotic expression has the most significant share as they are cheaper compared to others. By product type, protein expression market is segmented as a reagent, instruments, and services. Among all reagents are expected to have high growth rate during the forecast period 2018-2024, due to increase in research activities and vaccines. The application is segregated into therapeutic, industrial, research and others. Therapeutic is expected to have the most significant share in the market due to chronic diseases.

Biotechnology and pharmaceutical are leading in protein expression among end users owing to the rise in technological advancements, research, and manufacturing of therapeutic proteins. By Geography, Germany and Spain are dominating the protein expression market, and the growth in Europe is mainly attributed because of the increasing adoption of well-established healthcare facilities and R&D activities. Furthermore, UK is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.

Europe Protein Expression Market Segments Trends:

  • Europe Protein expression equipment such as ultrasound systems and dialysis bags perform tasks with higher accuracy, speed and help to reduce cost.
  • New technologies such as NEB expression technology provide a strategy that best suitable for your protein expression and purification need.
  • In July 2017, Domainex Ltd.And NCE Discovery has merged to produce a new drug on NTP-nucleotide triphosphate.

Europe Protein Expression Research Report:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOTanalysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
  • Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
  • Identifying DROC in the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
  • Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
  • Jena Bioscience GmbH
  • Domainex Ltd.
  • ARTES Biotechnology GmbH
  • Peak Proteins Ltd.
  • Oxford Expression Technologies Ltd.

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2Porter’s five force analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 Pestle Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1. Drivers

4.1.1Rising R&D in pharma sector for the development of innovative technologies

4.1.2 Increasing number of population with chronic diseases

4.1.3 Availability of funds by the Government

4.2 Restraints

4.2.1 High cost of protein expression reagents

4.3 Opportunities

4.3.1 Increasing usage in proteomics

4.3.2 Suitability of protein expression reagents for vaccines and other medicinal drugs

4.4 Challenges

4.4.1.Protein purification

4.4.2. Complexities with the membrane of protein expression

Chapter 5 EuropeProtein Expression Market – By Expression

5.1 Prokaryotic Expression

5.2 Cell-Free Expression

5.3 Insect Expression

5.4Mammalian Expression

5.5 Yeast Expression

Chapter 6 EuropeProtein Expression Market – By Product

6.1 Reagents

6.2 Instruments

6.3 Others

Chapter 7 Europe Protein Expression Market – By Application

7.1 Therapeutic

7.4 Cell Culture

7.5 Others

Chapter 8 EuropeProtein Expression Market – By End-User


8.2 Pharmaceutical

8.3 Research & Education

8.4 Others

Chapter 9 Europe Protein Expression Market – By Geography

9.1 Introduction

9.2 Europe

9.2.1.  U.K.

9.2.2.  Germany

9.2.3.  France

9.2.4. Italy

9.2.5.  Spain

9.2.6. Rest of Europe

Chapter 10 Europe Protein Expression Market – Company Profiles

10.1. Jena Bioscience GmbH

10.2.Domainex Ltd.

10.3.ARTES Biotechnology GmbH

10.4.Peak Proteins Ltd.

10.5. Oxford Expression Technologies Ltd.

10.6. Bio-Rad Technologies

10.7.Merck KgaA

10.8. Qiagen N.V


10.10. Promega Corporation

10.11.Accelagen Inc.

10.12. New England Biolabs, Inc.

10.13.Synthetic Genomics Inc.

10.14.Sigma Aldrich Corporation

10.15. Thermo Fisher Scientific Inc.

Chapter 11 EuropeProtein Expression Market – Competitive Landscape

11.1.Market Share Analysis

11.2.Strategies Adopted by top companies

11.3.Mergers, Acquisitions, Collaborations & Agreements

Chapter 12Market Insights

12.1. Industry Experts Insights

12.2.Analysts Opinions

12.3.Investment Opportunities

Chapter 13 Appendix

13.1 List of Tables

13.2 List of Figures


  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.